CONMED Corporation (CNMD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for CONMED Corporation, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 26.78x | 15.94x | 52.10x | -33.04x | 66.10x | 336.35x |
| P/B Ratio | 1.22x | 2.19x | 4.03x | 3.57x | 5.26x | 4.51x |
| P/S Ratio | 0.92x | 1.62x | 2.70x | 2.55x | 4.09x | 3.71x |
| Profitability | ||||||
| Gross Margin | 52.8% | 56.1% | 54.3% | 54.6% | 56.2% | 53.4% |
| Operating Margin | 10.3% | 15.3% | 9.7% | 6.7% | 10.9% | 5.3% |
| Net Margin | 3.4% | 10.1% | 5.2% | -7.7% | 6.2% | 1.1% |
| EBITDA Margin | 14.1% | 20.8% | 15.5% | 0.7% | 17.7% | 13.7% |
| Liquidity | ||||||
| Current Ratio | 2.14x | 2.30x | 1.98x | 1.96x | 2.34x | 2.19x |
| Quick Ratio | 1.01x | 1.05x | 0.96x | 0.84x | 1.16x | 1.17x |
| Leverage | ||||||
| Debt/Equity | 0.81x | 0.94x | 1.19x | 1.41x | 0.87x | 1.10x |
YoY = year-over-year change. Source: FMP..